Evidence map›Paper›PMID 30626191›Full record

ArticleAIDS care2018

Resilience after withdrawing a technology-based medication adherence support intervention from people living with HIV in rural Uganda.

Angella Musiimenta, Esther C Atukunda, Wilson Tumuhimbise, Jessica E Haberer

Open access · bronzeAbstract read
In one paragraph

Article in AIDS care, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Angella Musiimentaa Mbarara University of Science and Technology , Mbarara , Uganda.
Esther C Atukundaa Mbarara University of Science and Technology , Mbarara , Uganda.
Wilson Tumuhimbisea Mbarara University of Science and Technology , Mbarara , Uganda.
Jessica E Habererb Harvard Medical School , Boston , MA , USA.
Mbarara University of Science and Technology · UGHarvard University · US

Funding

Optimizing mHealth for adherence monitoring and interventionK24MH114732 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI HABERER, JESSICA ELIZABETH · 2017 to 2021
$800k
Real time Tuberculosis Medication Adherence Intervention in Rural Southwestern UgandaK43TW010388 · FIC · MBARARA UNIVERSITY/SCIENCE/ TECHNOLOGY · PI MUSIIMENTA, ANGELLA · 2016 to 2021
$602k
Development of Real-Time Antiretroviral Therapy Adherence Intervention in UgandaR34MH100940 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI HABERER, JESSICA ELIZABETH · 2013 to 2015
$593k
Patient-centered mobile technology interventions to improve maternal health in UgandaK43TW011004 · FIC · MBARARA UNIVERSITY/SCIENCE/ TECHNOLOGY · PI ATUKUNDA, ESTHER CATHYLN · 2018 to 2022
$542k
FIC NIH HHS K43 TW010388FIC NIH HHS K43 TW011004NIMH NIH HHS K24 MH114732NIMH NIH HHS R34 MH100940
6 · The paper itself

Abstract

Technology-based interventions for behavior change, such as adherence monitors and SMS text messages, can improve adherence to HIV antiretroviral therapy. It is unclear, however, how the effects of such interventions are maintained when interventions are withdrawn. We explored resiliency of people living with HIV in coping with adherence to antiretroviral therapy (ART) after withdrawing an adherence support intervention of real-time adherence monitors linked to SMS text messages at study closure. This is a qualitative study conducted with former participants of a pilot randomized controlled trial after study closure. Between April 2016 and November 2016, we used convenient sampling to interview 28 of the 62 participants from the pilot trial, which was conducted in rural Uganda. Interviews elicited information on experiences of taking ART in the absence of the intervention, coping strategies, and changes in social support interactions. Data were analyzed inductively using content analysis. Most participants demonstrated resilience through learning adherence from the intervention; and internalizing the habit of medication adherence. They seemed to have a sense of self-esteem, positive thinking, and access to supportive relationships. Other participants employed adaptive coping strategies, such as using alternative cues (e.g., alarms), accessing spiritual support, and adjusting their medication time to their routine. A few participants lacked resiliency, lost the habit and struggled with adherence. They were dependent on the intervention, appeared isolated and psychologically stressed, and were unable to overcome challenges associated with poor social support systems. Intervention-related benefits may or may not persist after the intervention is withdrawn. Contingent on individuals" underlying characteristics and relationships, participants manifested resiliency through learning and internalization, as well as using alternative coping strategies. Such resiliency could facilitate the use of short-term interventions, which are particularly important for resource-limited settings. Participants should be referred to available additional support at study closure when needed.

Indexed as

Resilience, PsychologicalRural PopulationAdultAnti-HIV AgentsFemaleHIV InfectionsHumansMaleMedication AdherencePilot ProjectsQualitative ResearchRandomized Controlled Trials as TopicResearch DesignSocial SupportText MessagingUgandaAnti-HIV Agentsintervention dependencepost-intervention experiencesreal-time adherence monitoringResiliencesustaining behavior

Identifiers

PMID30626191
PMCPMC6531604
OpenAlexW2908633803

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.